Health Condition 1: L814- Other melanin hyperpigmentation
Conditions
Interventions
Intervention1: G-lite Cream
Artocarpus Extract (Oxyresveratrol) 0.1% + Kojic Acid Dipalmitate 2% + Arbutin 1.5% + Licorice Extract 1% + Niacinamide 3% + Mulberry Extract 1% + Alpha Tocopherol 1% + All
Sponsors
Gufic Biosciences Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female and male patients, from 18-45 years of age with hyperpigmentation 2.Participants who are willing to provide a written informed consent and photo consent form 3.Participants who are willing to follow up for three visits over a period of 12 weeks (approximately). 4.Participants who are able and willing to follow all the study procedures including abstinence from usage of any OTC product related to face applications. 5.Participants who are willing to be clinically photographed as per protocol
Exclusion criteria
Exclusion criteria: 1.Patient who is not willing to participate in the study. 2.Patients who are using other pigment reduction creams. (Except sunscreen, a base moisturiser) 3.Subjects with other dermatological disorder of the face that may interfere with the study evaluation (Acne, DPN, Seborrheic melanosis) 4.Subjects with known hypersensitivity to any of the study drugs or constituents. 5.Subjects who are expected to be exposed to the triggering factors. (Excessive sun exposure, UVB photo therapy, use of OCPs) 6.Patient who has received facial procedures like dermabrasion, chemical peels or laser procedures within the last 1 month. 7.Any patient as per investigator’s opinion is unfit for participation in the study. 8.Pregnant / lactating females
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect assessed in terms of reduction in epidermal pigmentation assessed clinically, dermoscopically and by using Fotofinder.Timepoint: After 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the effect of G-lite on reduction of hyperpigmentation by using Dermacatch, clinical assessment, Dermoscopic & photographic assessment baseline visit (visit1, Day 0). They will be followed on Visit 2, (6th week) and Visit 3, (12th week).Timepoint: After 3 Months | — |
Countries
India
Contacts
Public ContactDr B S Chandrashekar
CUTIS Academy of Cutaneous Sciences
Outcome results
None listed